Eloxx Pharmaceuticals, Inc. (ELOX)
ELOX Stock Price Chart
Explore Eloxx Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ELOX price movements and trends.
ELOX Company Profile
Discover essential business fundamentals and corporate details for Eloxx Pharmaceuticals, Inc. (ELOX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Apr 1999
Employees
18.00
Website
https://www.eloxxpharma.comCEO
Sumit Aggarwal
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
ELOX Financial Timeline
Browse a chronological timeline of Eloxx Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 2 Apr 2025
Earnings released on 26 Mar 2025
Earnings released on 27 Dec 2024
Earnings released on 16 Aug 2024
Earnings released on 17 Jun 2024
Earnings released on 29 Mar 2024
Earnings released on 13 Nov 2023
EPS came in at -$1.31 surpassing the estimated -$1.97 by +33.50%.
Earnings released on 14 Aug 2023
EPS came in at -$1.96 falling short of the estimated -$1.54 by -27.27%.
Earnings released on 15 May 2023
EPS came in at -$2.88 falling short of the estimated -$2.55 by -12.94%.
Earnings released on 3 Apr 2023
EPS came in at -$2.92 surpassing the estimated -$2.97 by +1.68%.
Stock split effective on 2 Dec 2022
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Nov 2022
EPS came in at -$3.60 surpassing the estimated -$4.40 by +18.18%.
Earnings released on 15 Aug 2022
EPS came in at -$4.80 falling short of the estimated -$4.00 by -20.00%.
Earnings released on 10 May 2022
EPS came in at -$5.36 .
Earnings released on 6 May 2022
EPS came in at -$5.20 falling short of the estimated -$3.60 by -44.44%.
Earnings released on 9 Nov 2021
EPS came in at -$4.40 surpassing the estimated -$5.60 by +21.43%.
Earnings released on 16 Aug 2021
EPS came in at -$8.00 falling short of the estimated -$5.20 by -53.85%.
Earnings released on 6 May 2021
EPS came in at -$8.80 falling short of the estimated -$6.40 by -37.50%.
Earnings released on 11 Mar 2021
EPS came in at -$6.00 surpassing the estimated -$8.80 by +31.82%.
Earnings released on 5 Nov 2020
EPS came in at -$6.40 surpassing the estimated -$7.60 by +15.79%.
ELOX Stock Performance
Access detailed ELOX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.